Lamotrigine 250 mg/1 (Lamotrigine Extended-Release TABLET, FILM COATED, EXTENDED RELEASE) 250 mg/1

Lamotrigine 250 mg extended-release tablets are used to manage certain types of seizures and mood disorders. This extended-release formulation is designed for consistent medication levels in the body.

Strength

250 mg/1

Pack Size

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-244-30)

Manufacturer / TM Owner

Camber Pharmaceuticals Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lamotrigine is primarily used as an anticonvulsant to treat epilepsy and manage bipolar disorder. It works by stabilizing electrical activity in the brain, which can help prevent seizures and mood swings. People often ask, 'What is lamotrigine used for?' It is commonly prescribed for conditions like tonic-clonic seizures, partial seizures, and bipolar disorder to maintain stable moods.

Side Effects

Common effects of lamotrigine may include dizziness, headache, nausea, and blurred vision. Some users report feeling tired or experiencing skin rashes. These effects can vary and are not experienced by everyone.

Precautions & Warnings

Lamotrigine should be handled with care, especially regarding dosage adjustments and potential allergic reactions. It is important to follow medical advice and monitor for any severe skin reactions. Always store the medication in a cool, dry place away from children.

Avoid Interactions

Lamotrigine may interact with other medications, including birth control pills, antidepressants, and certain anticonvulsants. Alcohol and other central nervous system depressants should be used cautiously. Always consult a healthcare provider before combining medications.

Frequently Asked Questions

Lamotrigine is used to treat epilepsy and bipolar disorder by stabilizing electrical activity in the brain.

Lamotrigine extended-release tablets should be taken orally, usually once or twice daily, as directed by a healthcare provider.

Common side effects include dizziness, headache, nausea, and blurred vision. Severe skin reactions are rare but require immediate medical attention.

Alcohol should be used cautiously while taking lamotrigine, as it may increase the risk of side effects.

Store lamotrigine tablets in a cool, dry place away from children and direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.